Revolutionizing Protein Design with EvolutionaryScale’s ESM3 Model
EvolutionaryScale has introduced its latest ESM3 model, marking a significant leap in the realm of protein design. This advanced model, developed by a Meta FAIR spinoff, leverages cutting-edge technology to enable engineers to delve into the world of proteins with unprecedented precision and programmability. With a recent round of funding led by Lux Capital and backing from industry giants like NVIDIA, EvolutionaryScale is poised to drive innovation in programmable biology, offering new possibilities in healthcare, environmental sustainability, and beyond.
Empowering Protein Discovery with ESM3
- The ESM3 model, powered by NVIDIA H100 Tensor Core GPUs, represents a milestone in computational biology with its 98 billion parameters and enhanced data processing capabilities.
- This revolutionary model has been trained on a database of over 2 billion protein sequences, enabling researchers to accelerate protein discovery and development.
- EvolutionaryScale’s ESM3 model is positioned to transform the landscape of drug development, disease research, and evolutionary studies with its AI-driven approach to protein engineering.
Innovations in Biological Research with ESM3
EvolutionaryScale’s ESM3 model opens up new horizons for in silico biological research, offering scientists a powerful tool to explore the complexities of protein structures and functions. Key highlights of ESM3 include:
- Training on a vast dataset of 2.8 billion protein sequences from diverse sources, enabling accurate identification and validation of novel proteins.
- A generative design approach that allows for input-driven structure and function annotations, facilitating customized protein modeling for specific research needs.
- An expansive generative training framework that enhances the scalability and efficiency of protein design processes in biological research.
Unlocking Breakthroughs in Protein Design with NVIDIA BioNeMo
ESM3, in conjunction with NVIDIA BioNeMo, empowers biologists and protein designers to push the boundaries of protein engineering through AI-driven innovations. Noteworthy features of ESM3 and BioNeMo integration include:
- Quick generation of new proteins based on user prompts, scaffold designs, and feedback mechanisms, enabling iterative improvements in protein design.
- Enhanced functionality for designing proteins tailored to specific requirements, offering researchers a versatile platform for custom protein engineering.
- Future applications in drug discovery, environmental solutions, and biotechnological advancements driven by the collaborative efforts of EvolutionaryScale and NVIDIA.
Exploring the Future of Protein Engineering
EvolutionaryScale is set to release an API for ESM3, providing researchers with access to this groundbreaking technology for closed beta testing. By collaborating with NVIDIA and leveraging state-of-the-art computing resources, EvolutionaryScale aims to revolutionize protein design and make significant strides in various scientific domains.
By
By
By
By